Comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment

被引：2
|
作者：
Calugaru, Dan [1 ]
Calugaru, Mihai [1 ]
机构：
[1] Univ Med Cluj Napoca, Dept Ophthalmol, Cluj Napoca, Romania
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2017年 / 27卷 / 03期
关键词：
D O I：
10.5301/ejo.5000898
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E104 / E105
页数：2
相关论文
共 50 条
  • [31] Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema Extrapolation of Data to Clinical Practice
    Heier, Jeffrey S.
    Bressler, Neil M.
    Avery, Robert L.
    Bakri, Sophie J.
    Boyer, David S.
    Brown, David M.
    Dugel, Pravin U.
    Freund, K. Bailey
    Glassman, Adam R.
    Kim, Judy E.
    Martin, Daniel F.
    Pollack, John S.
    Regillo, Carl D.
    Rosenfeld, Philip J.
    Schachat, Andrew P.
    Wells, John A., III
    JAMA OPHTHALMOLOGY, 2016, 134 (01) : 95 - 99
  • [32] The effect and safety of intravitreal injection of ranibizumab and bevacizumab on the corneal endothelium in the treatment of diabetic macular edema
    Guzel, Huseyin
    Bakbak, Berker
    Koylu, Mehmet Talay
    Gonul, Saban
    Ozturk, Banu
    Gedik, Sansal
    CUTANEOUS AND OCULAR TOXICOLOGY, 2017, 36 (01) : 5 - 8
  • [33] Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
    Glassman, Adam R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [34] Intravitreal Bevacizumab in the Treatment of Diabetic Macular Edema
    Salvetti, P. A.
    Bonavia, L.
    Rosina, C.
    Sabella, P.
    Draghi, M.
    Staurenghi, G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [35] Critical appraisal of ranibizumab in the treatment of diabetic macular edema
    Stewart, Michael W.
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1257 - 1267
  • [36] High Dose Ranibizumab in the Treatment of Diabetic Macular Edema
    Marzette, L. A.
    Gloth, J.
    Beer, P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [37] Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy
    Gulkilik G.
    Taskapili M.
    Kocabora S.
    Muftuoglu G.
    Demirci G.
    International Ophthalmology, 2010, 30 (6) : 697 - 702
  • [38] Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
    Bressler, Neil M.
    Varma, Rohit
    Suner, Ivan J.
    Dolan, Chantal M.
    Ward, James
    Ehrlich, Jason S.
    Colman, Shoshana
    Turpcu, Adam
    OPHTHALMOLOGY, 2014, 121 (12) : 2461 - 2472
  • [39] INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA
    Zhioua, Imene
    Semoun, Oudy
    Lalloum, Franck
    Souied, Eric H.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (07): : 1429 - 1435
  • [40] Choroidal Thickness After Dexamethasone Implant or Aflibercept in Patients with Diabetic Macular Edema Persistent to Ranibizumab
    Aksoy, Mustafa
    Yilmaz, Gursel
    Vardarli, Irfan
    Akkoyun, Imren
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 36 (08) : 629 - 635
12345